Intellipharmaceutics International (I) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock I Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Intellipharmaceutics International Inc. (IPCIQ)December 18, 2024 | finance.yahoo.comIPCIQ Intellipharmaceutics International Inc.November 23, 2024 | seekingalpha.comIntelliPharmaCeutics International Inc IPCIQNovember 23, 2024 | morningstar.comMSuper Generics Market Size Will Reach USD 128.62 Billion to 2031 - Revealed InsightAce Latest StudyApril 22, 2024 | finance.yahoo.comIntelliPharmaCeutics Intl: Top 10 Undervalued Biotechnology Industry Stocks (IPCI)February 19, 2024 | theglobeandmail.comClosing Bell: Intellipharmaceutics International Inc up on Wednesday (IPCI)January 3, 2024 | theglobeandmail.comClosing Bell: Intellipharmaceutics International Inc up on Tuesday (IPCI)December 7, 2023 | theglobeandmail.comIntellipharmaceutics International GAAP EPS of -$0.06October 16, 2023 | msn.comClosing Bell: Intellipharmaceutics International Inc down on Friday (IPCI)October 13, 2023 | theglobeandmail.comClosing Bell: Intellipharmaceutics International Inc down on Wednesday (IPCI)July 5, 2023 | theglobeandmail.comClosing Bell: Intellipharmaceutics International Inc down on Tuesday (IPCI)June 29, 2023 | theglobeandmail.comClosing Bell: Intellipharmaceutics International Inc down on Monday (IPCI)June 13, 2023 | theglobeandmail.comIntellipharmaceutics International Inc. (I4AA.F)April 18, 2023 | finance.yahoo.comClosing Bell: Intellipharmaceutics International Inc flat on Wednesday (IPCI)April 7, 2023 | theglobeandmail.comClosing Bell: Intellipharmaceutics International Inc flat on Monday (IPCI)April 5, 2023 | theglobeandmail.comClosing Bell: Intellipharmaceutics International Inc flat on Friday (IPCI)April 4, 2023 | theglobeandmail.comIntellipharmaceutics Provides Update on Management Cease Trade Order Application and Anticipates Cease Trade OrderFebruary 7, 2023 | yahoo.comIntellipharmaceutics International Inc. (IPCIF)January 13, 2023 | finance.yahoo.comChanges at the Top for Endo Could Benefit Its Smaller PartnersAugust 30, 2022 | thestreet.comIntellipharmaceutics International IncAugust 23, 2022 | reuters.comIntellipharmaceutics International Inc.: Intellipharmaceutics Announces Second Quarter 2022 ResultsJuly 23, 2022 | finanznachrichten.deIntellipharmaceutics Announces Second Quarter 2022 ResultsJuly 21, 2022 | finance.yahoo.comStocks in play: Intellipharmaceutics International Inc.July 15, 2022 | ca.finance.yahoo.comIntellipharmaceutics International Inc.: Intellipharmaceutics Announces First Quarter 2022 ResultsApril 14, 2022 | finanznachrichten.deIntellipharmaceutics Announces First Quarter 2022 ResultsApril 14, 2022 | stockhouse.comIntellipharmaceutics International Inc.: Intellipharmaceutics Announces Fiscal Year 2021 ResultsFebruary 28, 2022 | finanznachrichten.deIntellipharmaceutics International Inc.: Intellipharmaceutics Mourns the Death of Valued Board Member Kenneth Eugene KeirsteadJanuary 13, 2022 | finanznachrichten.deIntellipharmaceutics International Inc (IPCIF)January 7, 2022 | nasdaq.comIntellipharmaceutics Announces Third Quarter 2021 ResultsOctober 15, 2021 | finance.yahoo.comNorth American Morning Briefing: Investors to -2-October 14, 2021 | morningstar.comM'I fit here perfectly': Adames reflects on meteoric rise with BrewersAugust 21, 2021 | msn.com'He has allergies': Parents in Palm Beach County react to school district's updated stay-at-home orderAugust 19, 2021 | msn.com‘If Masa said yes, who am I to object?’: SoftBank deals unleash internal compliance tensionsAugust 8, 2021 | ft.comSome public health officials want R.I. to enforce masks indoorsAugust 5, 2021 | msn.comBlack and Latino caucus leader calls for R.I. to include minority-owned businessesAugust 5, 2021 | msn.comFootball's A.I. future? How former Premier League player is showing top clubs who to sign, and whenAugust 3, 2021 | dailymail.co.ukBlack and Latino caucus calls for R.I. to comply with state contract requirementJuly 29, 2021 | msn.comMaharashtra again cuts up to 25% syllabus from class I to XIIJuly 23, 2021 | msn.com Get Intellipharmaceutics International News Delivered to You Automatically Sign up to receive the latest news and ratings for I and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. I Media Mentions By Week I Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. I News Sentiment▼0.001.14▲Average Business Services News Sentiment I News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. I Articles This Week▼00▲I Articles Average Week Get the Latest News and Ratings for I and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Intellipharmaceutics International and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Amex Exploration News Corus Entertainment News TELUS News BCE News Rogers Communications News Rogers Communications News JOY News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:I) was last updated on 9/1/2025 by MarketBeat.com Staff From Our PartnersRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the mo...The Oxford Club | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intellipharmaceutics International Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Intellipharmaceutics International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
